LEADER 01111nam2-2200373---450-
001 990005852890203316
005 20130617145550.0
010   $a978-3-7091-1510-7
035   $a000585289
035   $aUSA01000585289
035   $a(ALEPH)000585289USA01
035   $a000585289
100   $a20130603d2013----km-y0itay50------ba
101   $aeng
102   $aGB
105   $aa---||||001yy
200 1 $aSphingolipids in disease$fErich Gulbins, Irina Petrache
210   $aNew York$cSpringer$d2013
215   $aVIII, 478 p.$cill.$d24 cm
225 2 $aHandbook of experimental pharmacology$v216
410  0$1001000320432$aHandbook of experimental pharmacology$v, 216
610 0 $aSfingolipidi
676   $a616.399
702  1$aGULBINS,$bErich
702  1$aPETRACHE,$bIrina
801  0$aIT$bsalbc$gISBD
912   $a990005852890203316
951   $a616.399 SPH 2$b5682 Farm.$c616.399$d00293038
959   $aBK
969   $aFAR
979   $aIANNONE$b90$c20130603$lUSA01$h1151
979   $aIANNONE$b90$c20130617$lUSA01$h1455
996   $aSphingolipids in disease$91087180
997   $aUNISA